Published in Regul Toxicol Pharmacol on February 19, 2010
Elucidating the mechanisms of nickel compound uptake: a review of particulate and nano-nickel endocytosis and toxicity. Toxicol Appl Pharmacol (2011) 0.94
Translational toxicology in setting occupational exposure limits for dusts and hazard classification - a critical evaluation of a recent approach to translate dust overload findings from rats to humans. Part Fibre Toxicol (2015) 0.90
Response to the Reply on behalf of the 'Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area' (MAK Commission) by Andrea Hartwig Karlsruhe Institute of Technology (KIT). Part Fibre Toxicol (2016) 0.75
Incorporation of dosimetry in the derivation of reference concentrations for ambient or workplace air: a conceptual approach. J Aerosol Sci (2016) 0.75
Safe handling of nanotechnology. Nature (2006) 7.25
Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect (2006) 3.16
Ultrafine particle deposition in humans during rest and exercise. Inhal Toxicol (2003) 2.06
Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol (2009) 1.78
Ultrafine particles in the urban air: to the respiratory tract--and beyond? Environ Health Perspect (2002) 1.76
The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials (2008) 1.68
Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect (2007) 1.65
Meeting report: hazard assessment for nanoparticles--report from an interdisciplinary workshop. Environ Health Perspect (2007) 1.64
Does Nanoparticle Activity Depend upon Size and Crystal Phase? Nanotoxicology (2008) 1.62
Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J Toxicol Environ Health A (2010) 1.61
Interlaboratory evaluation of rodent pulmonary responses to engineered nanomaterials: the NIEHS Nano GO Consortium. Environ Health Perspect (2013) 1.52
Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. ACS Nano (2010) 1.49
Pulmonary function, diffusing capacity, and inflammation in healthy and asthmatic subjects exposed to ultrafine particles. Inhal Toxicol (2004) 1.45
Inhalation of ultrafine particles alters blood leukocyte expression of adhesion molecules in humans. Environ Health Perspect (2006) 1.44
Ultrafine particle deposition in subjects with asthma. Environ Health Perspect (2004) 1.40
Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology. Toxicol Sci (2005) 1.30
The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicol Sci (2005) 1.29
Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma. Res Rep Health Eff Inst (2004) 1.25
Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation. Part Fibre Toxicol (2014) 1.24
Translocation and effects of ultrafine particles outside of the lung. Clin Occup Environ Med (2006) 1.20
Changes in deceleration capacity of heart rate and heart rate variability induced by ambient air pollution in individuals with coronary artery disease. Part Fibre Toxicol (2010) 1.16
Concepts of nanoparticle dose metric and response metric. Environ Health Perspect (2007) 1.12
Continued controversy on chrysotile biopersistence. Int J Occup Environ Health (2011) 1.12
The origin, fate, and health effects of combustion by-products: a research framework. Environ Health Perspect (2002) 1.10
Nanotoxicology: in vitro-in vivo dosimetry. Environ Health Perspect (2012) 1.09
Systemic effects of inhaled ultrafine particles in two compromised, aged rat strains. Inhal Toxicol (2004) 1.04
Recirculating air filtration significantly reduces exposure to airborne nanoparticles. Environ Health Perspect (2008) 1.03
Activation of pulmonary dendritic cells and Th2-type inflammatory responses on instillation of engineered, environmental diesel emission source or ambient air pollutant particles in vivo. J Innate Immun (2010) 1.03
Validation of an LDH assay for assessing nanoparticle toxicity. Toxicology (2011) 1.03
ECG parameters and exposure to carbon ultrafine particles in young healthy subjects. Inhal Toxicol (2009) 1.02
Induction of chemokines by low-dose intratracheal silica is reduced in TNFR I (p55) null mice. Toxicol Sci (2003) 1.01
A nanoparticle dispersion method for in vitro and in vivo nanotoxicity study. Nanotoxicology (2010) 1.00
On-road exposure to highway aerosols. 2. Exposures of aged, compromised rats. Inhal Toxicol (2004) 0.98
Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med (2005) 0.97
Early postnatal exposure to ultrafine particulate matter air pollution: persistent ventriculomegaly, neurochemical disruption, and glial activation preferentially in male mice. Environ Health Perspect (2014) 0.97
Developmental exposure to concentrated ambient particles and preference for immediate reward in mice. Environ Health Perspect (2012) 0.92
Nanoparticle (NP) uptake by type I alveolar epithelial cells and their oxidant stress response. Nanotoxicology (2009) 0.92
Application of an informatics-based decision-making framework and process to the assessment of radiation safety in nanotechnology. Health Phys (2015) 0.91
Effects of on-road highway aerosol exposures on autonomic responses in aged, spontaneously hypertensive rats. Inhal Toxicol (2007) 0.90
Short-term effects of air pollution: a panel study of blood markers in patients with chronic pulmonary disease. Part Fibre Toxicol (2009) 0.90
Extraction and quantification of carbon nanotubes in biological matrices with application to rat lung tissue. ACS Nano (2013) 0.89
Time course of lung retention and toxicity of inhaled particles: short-term exposure to nano-Ceria. Arch Toxicol (2014) 0.88
Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data. Toxicology (2012) 0.86
Endotoxin potentiates ozone-induced pulmonary chemokine and inflammatory responses. Exp Lung Res (2002) 0.86
Impact of ambient air pollution on the differential white blood cell count in patients with chronic pulmonary disease. Inhal Toxicol (2010) 0.86
Formation of PAH-DNA adducts after in vivo and vitro exposure of rats and lung cells to different commercial carbon blacks. Toxicol Appl Pharmacol (2005) 0.85
Derivation of PM10 size-selected human equivalent concentrations of inhaled nickel based on cancer and non-cancer effects on the respiratory tract. Inhal Toxicol (2014) 0.77
Quantitative risk analyses for RCF: survey and synthesis. Regul Toxicol Pharmacol (2003) 0.76
In vitro dosing of cells with poorly soluble particles. Toxicol Sci (2006) 0.76
Reducing exposure to airborne particles: a novel strategy to improve cardiovascular health. Am J Respir Crit Care Med (2008) 0.75
Report: Combustion Byproducts and Their Health Effects: Summary of the 10th International Congress. Environ Eng Sci (2008) 0.75
[Toxicity of nano silica particles on rat type I-like alveolar epithelial cells]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi (2009) 0.75